Microvascular pathology and vascular basement membrane components in Alzheimer's disease
- PMID: 7888105
- DOI: 10.1007/BF02816103
Microvascular pathology and vascular basement membrane components in Alzheimer's disease
Abstract
Several factors have highlighted the vasculature in Alzheimer's disease (AD): Cerebral amyloid angiopathy (CAA) is common, amyloid fibrils emanate from the vascular basement membrane (VBM), and similar forms of beta-amyloid are found in vascular and parenchymal amyloid accumulations. The present article discusses the presence of microvascular pathology in AD. Microangiopathy, in addition to neurofibrillary tangles, senile plaques, and CAA, is a common pathologic hallmark of AD. VBM components are associated with amyloid plaques, and nonamyloidotic alterations of the VBM occur in brain regions susceptible to AD lesions. Also, intra-VBM perivascular cells (traditionally called pericytes), a subset of which share the immunophenotype of microglia and other mononuclear phagocytic system (MPS) cells, have been implicated in vascular alterations and cerebrovascular amyloid deposition. Perivascular and parenchymal MPS cells have access to several sources of the beta-amyloid protein precursor, including platelets, circulating white cells, and neurons. MPS cells would thus be ideally situated to uptake and process the precursor, and deposit beta-amyloid in a fashion analogous to that seen in other forms of systemic and cerebral amyloidoses.
Similar articles
-
Vascular basement membrane pathology and Alzheimer's disease.Ann N Y Acad Sci. 1997 Sep 26;826:147-60. doi: 10.1111/j.1749-6632.1997.tb48467.x. Ann N Y Acad Sci. 1997. PMID: 9329687
-
Vascular basement membrane components and the lesions of Alzheimer's disease: light and electron microscopic analyses.Microsc Res Tech. 1994 Jun 15;28(3):204-15. doi: 10.1002/jemt.1070280305. Microsc Res Tech. 1994. PMID: 8068983
-
Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.Ann N Y Acad Sci. 2000 Apr;903:317-23. doi: 10.1111/j.1749-6632.2000.tb06382.x. Ann N Y Acad Sci. 2000. PMID: 10818521
-
Brain parenchymal and microvascular amyloid in Alzheimer's disease.Brain Pathol. 1996 Apr;6(2):179-95. doi: 10.1111/j.1750-3639.1996.tb00799.x. Brain Pathol. 1996. PMID: 8737932 Review.
-
The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.Ann N Y Acad Sci. 1999;893:113-25. doi: 10.1111/j.1749-6632.1999.tb07821.x. Ann N Y Acad Sci. 1999. PMID: 10672233 Review.
Cited by
-
Alzheimer's disease, brain immune privilege and memory: a hypothesis.J Neural Transm (Vienna). 2006 Nov;113(11):1697-707. doi: 10.1007/s00702-006-0524-4. Epub 2006 Aug 24. J Neural Transm (Vienna). 2006. PMID: 16932992 Review.
-
Basal lamina changes in neurodegenerative disorders.Mol Neurodegener. 2021 Dec 7;16(1):81. doi: 10.1186/s13024-021-00502-y. Mol Neurodegener. 2021. PMID: 34876200 Free PMC article. Review.
-
The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy.Front Aging Neurosci. 2014 Sep 19;6:251. doi: 10.3389/fnagi.2014.00251. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25285078 Free PMC article. Review.
-
Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele.PLoS One. 2012;7(7):e41636. doi: 10.1371/journal.pone.0041636. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848551 Free PMC article.
-
Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease.Mol Neurobiol. 1996 Jun;12(3):211-24. doi: 10.1007/BF02755589. Mol Neurobiol. 1996. PMID: 8884749 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical